. The latest one is ciprofloxacin oral suspension, generic equivalent of Bayer`s Cipro Oral Suspension, indicated for treatment of infections, with annual US sales of $9 million. Last year, Lupin had 31 approvals in the US, the largest number by an Indian pharma company. It expects to launch 25-30 products
9.29 PM Mar 10th
Source:VC Circle - British pharmaceutical giant GlaxoSmithKline Plc (GSK) has completed its voluntary open offer for the Indian pharma arm, spending around Rs 6,400 crore ($1.03 billion) to hike its holding to 75 per cent. The open offer was fully subscribed. The company
5.07 PM Mar 10th
and KFDA which takes us head on with competition. In addition, the deal also supported our plans to quickly expand our Finished Dosage portfolio with the existing a high quality API manufacturing base,%u201D he said. While the Granules-Auctus deal is valued at Rs.1.20 crore, the Indian pharma sector
10.43 PM Mar 3rd
and not dependent on US FDA whims and fancies that ofyen and suddenly strikes an Indian pharma company. However, Aurobindo as on date is in a very good position without any doubt. By year end, Thinksoft is expected to rule at 600 and Aurobindo above 1000 most likely. - CRESTCLUB
3.38 PM Mar 2nd
microsystem or Silicon Graphics, they would have fallen by the wayside long back. Similarly in the Indian pharma sector, it is impossible now for a company like Sun or Lupin or Auro to go down, but can be possible for a IPCA or a Jubilant or even Torrent pharma...
10.41 PM Feb 28th
Follow moneycontrol.comFacebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.